Shi, S., Xu, J., Wei, M., Li, J., Du, N., Liao, C., Yu, Q., Du, Y., Song, L., Wang, H., Yu, X. (2026). Safety, efficacy, and immunogenicity of adjuvant therapy with personalized cancer vaccine (PCV) RGL-270 in combination with adebrelimab and mFOLFIRINOX in resectable pancreatic ductal adenocarcinoma (PDAC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4231